U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Medical Devices
  3. Medical Devices News and Events
  4. CDRHNew - News and Updates
  5. Webinar – Registration & Listing Requirements for In Vitro Diagnostic Products (IVDs), Including Laboratory Developed Tests (LDTs) - 12/03/2024
  1. CDRHNew - News and Updates

Virtual | Virtual

Event Title
Webinar – Registration & Listing Requirements for In Vitro Diagnostic Products (IVDs), Including Laboratory Developed Tests (LDTs)
December 3, 2024

Date:
December 3, 2024
Time:
1:00 PM - 2:00 PM ET

Summary

On May 6, 2024, the U.S. Food and Drug Administration (FDA) issued a final rule amending the FDA's regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act (FD&C Act) including when the manufacturer of the IVD is a laboratory. Along with that amendment, the FDA outlined a policy to phase out, over the course of four years, its general enforcement discretion approach to laboratory developed tests (LDTs). FDA expects compliance with establishment registration and device listing requirements for most IVDs offered as LDTs by May 6, 2025 (Stage 2 of the phaseout policy).

On December 3, 2024, the U.S. Food and Drug Administration (FDA) will host a webinar to provide information on how to comply with registration and listing requirements for IVDs, including LDTs. 

Add this to my Calendar
Outlook users: Click link, select Open, then click Save & Close

If you have questions that you wish to submit for possible discussion during the webinar, please email CDRHWebinars@fda.hhs.gov. All questions must be received by October 31, 2024, to be considered for the discussion. Questions will not be taken during the live webinar.

Webinar Details

Registration is not necessary

Date: December 3, 2024

Time: 1:00 PM – 2:00 PM

Please dial in 15 minutes before the start of the call to allow time to connect.

We anticipate high attendance for this webinar and there is limited capacity. We encourage you to join early. However, due to the limited capacity we intend to post a recording and transcript as soon as possible following the webinar. 

Meeting Link: https://fda.zoomgov.com/j/1616994355?pwd=cWZhS2RucTU4ZUNLbGF5ZFN5Wlo5dz09

Passcode:  %KeTf9

Please note: Participants who join the webinar using the Zoom webinar link above should use computer audio (listen through their computer speakers and speaking through computer microphone/headset).

The dial-in information provided below is for participants who will be joining the webinar by phone only.

  • U.S. Callers Dial:  833-568-8864 (Toll Free)
    • For higher quality, dial a number based on your current location:
      • +1 669 254 5252 US (San Jose)
      • +1 646 964 1167 US (US Spanish Line)
      • +1 646 828 7666 US (New York)
      • +1 669 216 1590 US (San Jose)
      • +1 415 449 4000 US (US Spanish Line)
      • +1 551 285 1373 US (New Jersey)
  • International Callers Dial: Please check the international numbers available
  • Webinar ID: 161 699 4355
  • Passcode: 066992

Webinar Materials

The presentation, printable slides, and transcript will be available on this webpage and at CDRH Learn under "In Vitro Diagnostics." 

If you have questions about this webinar, please contact CDRH's Division of Industry and Consumer Education (DICE) at dice@fda.hhs.gov, 1-800-638-2041, or 301-796-7100.

Back to Top